Ojas Mahapatra, Mars Bioimaging

Mars Bioimaging has developed a mobile colour CT for high quality scanning of hands and wrists. It has FDA approval in the US and is selling to the orthopaedic & emergency markets in the US & NZ. Ojas became CEO to focus on the commercialisation of the product and lead the push into the market. Key lessons: find your customer (a large market) and only then start throwing money at it. You'll fail a lot more than you win – you need to push through

http://www.marsbioimaging.com/
At the MORGO retreats we hear incredible stories from people building tech companies out into the world. The Morgo Podcast shares these stories with you.

Look for The MORGO Podcast on your favourite podcast app and subscribe

More from the Morgo Podcast Series

Morgo Partners

With support from Cumulo9
Supported by New Zealand Trade & Enterprise